IVITF - Invictus MD Strategies Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

1.49

-0.01 (-0.67%)

At close: 3:52PM EDT

Stock chart is not supported by your current browser

Previous Close	1.50
Open	1.49
Bid	0.00 x 0
Ask	0.00 x 0
Day's Range	1.47 - 1.53
52 Week Range	0.71 - 2.76
Volume	67,389
Avg. Volume	230,171

Market Cap	133.272M
Beta	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	-0.40
Earnings Date	N/A
Forward Dividend & Yield	0.32 (34.19%)
Ex-Dividend Date	2016-11-17
1y Target Est	N/A

Trade prices are not sourced from all markets

All

News

Press Releases

CNW Group11 days ago
Invictus' Acreage Pharms Acquires 23 New Strains, Expanding Its Genetics Profile
Invictus' Acreage Pharms Acquires 23 New Strains, Expanding Its Genetics Profile
CNW Group17 days ago
Invictus Jumps to Top Five in Share Appreciation Among Canada's Leading Cannabis Companies for 2018 Q1
Invictus Jumps to Top Five in Share Appreciation Among Canada's Leading Cannabis Companies for 2018 Q1
PR Newswire25 days ago
Invictus' Chief Evangelist Officer Gene Simmons Tours AB Laboratories
Company Announces Commencement of 40,000 sq. ft. Construction Expansion Project VANCOUVER , March 27, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") ...
CNW Group25 days ago
Invictus' Chief Evangelist Officer Gene Simmons Tours AB Laboratories
Invictus' Chief Evangelist Officer Gene Simmons Tours AB Laboratories
PR Newswire26 days ago
Key On-Site Sales Inspection Completed for Acreage Pharms
FRA: 8IS1) is pleased to announce that Acreage Pharms has undergone its physical on site sales license inspection. Health Canada officials are now completing their report. Given Acreage Pharms' strong commitment to closely adhering to regulatory guidelines and requirements, the company remains confident it will pass this important regulatory step and gains its sales license.
CNW Group26 days ago
Key On-Site Sales Inspection Completed for Acreage Pharms
Key On-Site Sales Inspection Completed for Acreage Pharms
PR Newswirelast month
Invictus Opens TSX Venture Exchange Trading as GENE for the First Time
FRA: 8IS1) is pleased to announce that today, Gene Simmons, Chief Evangelist Officer for the company and its management team opened the trading day at the TSX Venture Exchange (TSXV). The appearance coincides with the company changing its share ticker from IMH to GENE.
CNW Grouplast month
Invictus Opens TSX Venture Exchange Trading as GENE for the First Time
Invictus Opens TSX Venture Exchange Trading as GENE for the First Time
PR Newswirelast month
Invictus Changes Canadian Ticker to GENE
FRA: 8IS1) is pleased to announce that the Company is changing its ticker on the TSX Venture Exchange from IMH to GENE effective on March 20, 2018. "The change in our share ticker to GENE reflects the participation of music legend and media mogul Gene Simmons, who joins Invictus as Chief Evangelist Officer and our enterprise vision of providing multiple genetics/strains to cannabis consumers globally as regulations permit" said Invictus Chairman and CEO Dan Kriznic.
CNW Grouplast month
Invictus Changes Canadian Ticker to GENE
Invictus Changes Canadian Ticker to GENE
PR Newswire2 months ago
Invictus' Acreage Pharms Receives Notification of Sales license Inspection
FRA: 8IS1) Acreage Pharms Ltd. ("Acreage Pharms") is pleased to announce that it has received notification from Health Canada (HC) that its sales license inspection has been scheduled for later in March and is anticipated to take up to three days. The Sales License Inspection is the last step prior to the issuance of a Sales License under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"). "As there are currently only 40 cannabis sales licenses under the ACMPR in Canada, receiving confirmation of our Sales License Inspection from Health Canada is a major milestone for Acreage Pharms.
CNW Group2 months ago
Invictus' Acreage Pharms Receives Notification of Sales license Inspection
Invictus' Acreage Pharms Receives Notification of Sales license Inspection
CNW Group2 months ago
Invictus Provides Updates on Business Operations
Invictus Provides Updates on Business Operations
PR Newswire2 months ago
Invictus' Acreage Pharms' Phase 2 Construction Near Completion
FRA: 8IS1) Acreage Pharms Ltd. ("Acreage Pharms") is pleased to announce construction of its Phase 2 facility is nearly complete, putting Acreage Pharms on track for 5,000 kg of cannabis production capacity this month. "Facility construction is one of the foundations of our progress at this point, and we are thrilled that our teams of building specialists are completing work on this ambitious schedule on time," said Dan Kriznic, Chairman and CEO of Invictus. Both the Phase 1 and Phase 2 facilities at Acreage Pharms, located in west-central Alberta, have a total of approximately 40,000 square feet with expected 5,000 kg of capacity beginning in February 2018, along with a further planned 80,000 square foot Phase 3 expansion for total combined production capacity of 19,000 kg in 2018.
CNW Group2 months ago
Invictus' Acreage Pharms' Phase 2 Construction Near Completion
Invictus' Acreage Pharms' Phase 2 Construction Near Completion
PR Newswire2 months ago
Invictus Receives $16.5 Million from Warrants and Option Exercises Since Dec 22, 2017 and Increases Funded Capacity in 2018 to 27,200 Kg
VANCOUVER , Feb. 5, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP.'s ("Invictus" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that it has received an ...
CNW Group2 months ago
Invictus Receives $16.5 Million from Warrants and Option Exercises Since Dec 22, 2017 and Increases Funded Capacity in 2018 to 27,200 Kg
Invictus Receives $16.5 Million from Warrants and Option Exercises Since Dec 22, 2017 and Increases Funded Capacity in 2018 to 27,200 Kg
CNW Group3 months ago
Invictus MD Jumpstarts Revenue Stream With Sale of First 120 kg of Flower to Canopy Growth Corporation; Signs Definitive Agreement to Increase Ownership of AB Laboratories in Ontario from 33.3% to 50%
Invictus MD Jumpstarts Revenue Stream With Sale of First 120 kg of Flower to Canopy Growth Corporation; Signs Definitive Agreement to Increase Ownership of AB Laboratories in Ontario from 33.3% to 50%
PR Newswire3 months ago
Invictus MD Jumpstarts Revenue Stream With Sale of First 120 kg of Flower to Canopy Growth Corporation; Signs Definitive Agreement to Increase Ownership of AB Laboratories in Ontario from 33.3% to 50%
FRA: 8IS1) is pleased to announce the sale of its first 120 kg of dried flower from AB Laboratories Inc. (AB Labs), the licensed production facility under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), near Hamilton to Canopy Growth Corporation (WEED.TO), putting Invictus MD's license holders on track for achieving 26,000 kg run-rate production capacity for 2018 with net capacity of 22,150 kilograms to Invictus MD. Additionally, the Company is pleased to announce that it has signed the definitive agreement to make its further strategic investment in AB Labs, from its current 33.3 percent ownership interest to 50 percent.
Newsfile3 months ago
IIROC Trade Resumption - Invictus MD Strategies Corp.
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2018) - Trading resumes in: Company: Invictus MD Strategies Corp. TSX-V Symbol: IMH ...
Newsfile3 months ago
IIROC Trade Halt - Invictus MD Strategies Corp.
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2018) - The following issues have been halted by IIROC: Company: Invictus MD Strategies Corp. TSX-V Symbol: IMH ...
CNW Group3 months ago
Invictus MD to Increase Investment in AB Laboratories; AB Laboratories Receives Sales License; AB Laboratories, AB Ventures and Acreage Pharms Target over 26,000 kg Capacity in 2018
Invictus MD to Increase Investment in AB Laboratories; AB Laboratories Receives Sales License; AB Laboratories, AB Ventures and Acreage Pharms Target over 26,000 kg Capacity in 2018
PR Newswire3 months ago
Invictus MD to Increase Investment in AB Laboratories; AB Laboratories Receives Sales License; AB Laboratories, AB Ventures and Acreage Pharms Target over 26,000 kg Capacity in 2018
VANCOUVER , Jan. 8, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that the Company has ...
Newsfile3 months ago
IIROC Trade Halt - Invictus MD Strategies Corp.
Vancouver, British Columbia--(Newsfile Corp. - January 5, 2018) - The following issues have been halted by IIROC: Company: Invictus MD Strategies Corp. TSX-V Symbol: IMH ...